{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:38:51Z","timestamp":1791149931742,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1038\/74630","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"378-379","source":"Crossref","is-referenced-by-count":8,"title":["Will therapeutic peptides be kryptonite for superantigens?"],"prefix":"10.1038","volume":"6","author":[{"given":"Patrick M.","family":"Schlievert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0400_378_CR1","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"JK Todd","year":"1978","unstructured":"Todd, J.K., Kapral, F.A., Fishaut, M. & Welch, T.R. Toxic shock syndrome associated with phage group I staphylococci. Lancet 2, 1116\u20131118 ( 1978).","journal-title":"Lancet"},{"key":"BFnm0400_378_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","volume":"321","author":"DL Stevens","year":"1989","unstructured":"Stevens, D.L. et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321, 1\u20137 ( 1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0400_378_CR3","first-page":"25","volume-title":"Effect of Microbes on the Immune System","author":"PM Schlievert","year":"2000","unstructured":"Schlievert, P.M., Kotb, M.Y. & Stevens, D.L. in Effect of Microbes on the Immune System (eds. Cunningham, M.W. & Fujinami, R.S.) 25\u201339 (Lippincott Williams & Wilkins, Philadelphia, 2000)."},{"key":"BFnm0400_378_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/74672","volume":"6","author":"G Arad","year":"2000","unstructured":"Arad, G., Levey, R. Hillman, D. & Kaempfer, R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation Nature Med. 6, 414\u2013 421 (2000).","journal-title":"Nature Med."},{"key":"BFnm0400_378_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1126\/science.2185544","volume":"248","author":"P Marrack","year":"1990","unstructured":"Marrack, P. & Kappler, J. The staphylococcal enterotoxins and their relatives. Science 248, 705\u2013 711 (1990).","journal-title":"Science"},{"key":"BFnm0400_378_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1074-7613(00)80646-9","volume":"9","author":"H Li","year":"1998","unstructured":"Li, H. et al. Three dimensional structure of the complex between a T cell receptor \u03b2 chain and the superantigen staphylococcal enterotoxin B. Immunity 9, 807\u2013816 ( 1998).","journal-title":"Immunity"},{"key":"BFnm0400_378_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/368711a0","volume":"368","author":"TS Jardetsky","year":"1994","unstructured":"Jardetsky, T.S. et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711\u2013718 (1994).","journal-title":"Nature"},{"key":"BFnm0400_378_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-2143(96)90161-4","volume":"127","author":"PM Schlievert","year":"1996","unstructured":"Schlievert, P.M., Assimacopoulos, A.P. & Cleary, P.P. Severe invasive group A streptococcal disease: Clinical description and mechanisms of pathogenesis. J. Lab. Clin. Med. 127, 13\u201322 ( 1996).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnm0400_378_CR9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1128\/IAI.55.5.1070-1076.1987","volume":"55","author":"J Parsonnet","year":"1987","unstructured":"Parsonnet, J., Gillis, Z.A., Richter, A.G. & Pier, G.B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin-1. Infect. Immun. 55, 1070\u20131076 (1987).","journal-title":"Infect. Immun."},{"key":"BFnm0400_378_CR10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.140.4.1022","volume":"140","author":"FD Finkelman","year":"1988","unstructured":"Finkelman, F.D., Katona, I.M., Mosmann, T.R. & Coffman, R.L. IFN-regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140, 1022\u2013 1027 (1988).","journal-title":"J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0400_378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0400_378","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0400_378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:13:21Z","timestamp":1684448001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0400_378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["BFnm0400_378"],"URL":"https:\/\/doi.org\/10.1038\/74630","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}